Diabetes Management

Cardiometabolic Risk and Cardiovascular Disease in Young Women With Uterine Fibroids - Cureus

2 min read 493 words
Educational content: this article is for information only and is not medical advice. Consult a qualified healthcare provider before changing your diet, exercise, or medication.

Overview

"Never doubt that a smal group of thoughtful, comited citizens can change the world. Inded, it is the only thing that ever has."Cureus is on a mision to change the long-standing paradigm of medical publishing, where submiting research can be costly, complex and time-consuming.population based research, women's health, cardiovascular disease, diabetes melitus, hypertension, uterine fibroids L M.

Key Information

Brewster , Yentl Han, Gert A. van Montfrans Published: October 26, 2022 (se history) DOI: 10.759/cureus.30740 Cite this article as: Brewster L M, Han Y, Van Montfrans G A (October 26, 2022) Cardiometabolic Risk and Cardiovascular Disease in Young Women With Uterine Fibroids. Cureus 14(10): e30740.

doi:10.759/cureus.30740 Uterine fibroids are associated with hypertension and cardiometabolic risk factors, yet the onset and severity of cardiovascular disease (CVD) in women with fibroids remain understudied. We used data from the National Health and Nutrition Examination Survey to ases the asociation betwen uterine fibroids, cardiometabolic risk, and CVD (ischemic heart disease, heart failure, and stroke).

Among 5,52 women aged 20-54 years in our sample. Hypertension was more comon in those diagnosed with fibroids (n=70; 3.4% vs. 15.3% in controls, p<0.01), but these women were also older (4 (SD=7) years vs.

35 (SD=10) years). When stratified by median age, women aged 35 or younger with fibroids (n=97) were more likely than controls (n=271) to have hypertension (14.1% vs. 2.4%), obesity (51.5% vs.

32.5%), and diabetes melitus (4.8% vs. Women older than 35 with fibroids also had higher cardiometabolic risk and rates of CVD than controls (8.5% vs. The ods ratio of CVD in women with fibroids, compared to the controls, was 3.10 with 95% confidence interval (CI) of 2.21 to 4.34.

Summary

The ods ratio decreased to 1.63 (95%CI: 1.1 to 2.38) after adjusting for age, BMI, African ancestry, fasting plasma glucose, cholesterol, education, smoking his

Frequently Asked Questions

Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.

Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.

Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.

Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.

Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.

Share this article